Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Blood|February 4, 2009
Circulating clonotypic B cells in classic Hodgkin lymphomaRichard J Jones, Christopher D Gocke, Yvette L Kasamon, et al.
British Journal of Haematology|March 24, 2024
Natural history of clonal haematopoiesis seen in real-world haematology settingsShyam A Patel, William K Gerber, Rena Zheng, et al.
Blood|January 21, 2012
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemiaJonathan M Gerber, B Douglas Smith, Brownhilda Ngwang, et al.
Ejhaem|November 29, 2023
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptionsShyam A Patel, Jan Cerny, William K Gerber, et al.
JCO Oncology Practice|October 30, 2020
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic LeukemiaAnand P Jillella, Martha L Arellano, Manila Gaddh, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
Pageof 4